Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer.
- Resource Type
- journal article
- Source
- Journal of Clinical Oncology; 7/10/2009, Vol. 27 Issue 20, p3385-3390, 6p
- Subject
- Language
- ISSN
- 0732183X